medigraphic.com
ISSN 1561-3070 (Electronic)

2022, Number 4

<< Back Next >>

Rev Cub Oftal 2022; 35 (4)

Use of oral sildenafil in the treatment of orbital lymphangioma

Abreu PFA, Roso QD, Bazán MM, González GJL, Pérez RAC

Language: Spanish
References: 15
Page:
PDF size: 285.51 Kb.


ABSTRACT

Orbital lymphatic malformations are benign, slow-growing, abortive, nonfunctional vascular malformations that occur mainly in the first decade of life. Therapeutic options in these cases present limited resolution, some treatments are usually aggressive and cause damage to the visual apparatus. We present a case of a 6-year-old female patient treated for proptosis of the left eye. The clinical-imaging diagnosis of lymphangioma of the orbit was made to show the results achieved in its treatment through the use of oral sildenafil, a therapeutic modality under study worldwide in the treatment of these conditions. The treatment with sildenafil in orbital lymphangioma proved to be effective in the improvement of the clinical and imaging picture. No adverse reactions were reported during treatment.


REFERENCES

  1. Abreu FA, Ortiz DL, Santos D, González JL, Fernández O, Caballero Y. Características clínicas y patológicas de los tumores orbitarios. Rev Cubana Oftalmología 2018[acceso 18/03/2022];31(2). Disponible en: Disponible en: http://www.revoftalmologia.sld.cu/index.php/oftalmologia/article/view/554/html_344 1.

  2. Salmon J. Kanski. Oftalmología Clínica. Un enfoque sistemático. 9th ed. Elsevier; 2021;129-133.

  3. . Abreu FA. Enfermedades de la órbita y su contenido. En: Oftalmología pediátrica. ECIMED 2018. Cap 27: 387-402.

  4. Basic and clinical science course. American Academy of Ophthalmology 2018. Vol 7. Cap 5: 67-102. Disponible en: https://www.aao.org/Assets/42d3d758-19da-4c32-9fee-cc7d8ff611fb/636312515443700000/bcsc1718-s04-pdf4.

  5. Prakash G, Siddartha M, Mohammed I, Arjun K, Swathi E. A Case of Intraorbital Intraconal lymphangioma with Post-traumatic Apoplexy. Journal of Pediatric Neurosciences 2018. DOI: http://dx.doi.org/10.4103/jpn.JPN_39_185.

  6. Patel SR, Rosenberg JB, Barmettler A. Interventions for orbital lymphangioma. Cochrane Database of Systematic Reviews 2019, Issue 5. Art. No.: CD013000. DOI: http://dx.doi.org/10.1002/14651858.cd013000.pub26.

  7. Young JW, Chang YK, Bradford S, Jin SY. Orbital Lymphangioma: Characteristics and Treatment Outcomes of 12 Cases. Korean J Ophthalmol. 2017;31(3):194-201. DOI: http://dx.doi.org/10.3341/kjo.2016.00347.

  8. Danial C, Tichy AL, Tariq U, Swetman GL, Khuu P, Leung TH, Benjamin L, Teng J, Vasanawala SS, Lane AT. An open-label study to evaluate sildenafil for the treatment of lymphatic malformations. J Am Acad Dermatol. 2014 Jun;70(6):1050-7. DOI: http://dx.doi.org/10.1016/j.jaad.2014.02.0058.

  9. Wang S, Zhang J, Ge W, Liu Y, Guo Y, Tai J et al. Use of Oral Sildenafil in Treatment of Pediatric Head and Neck Lymphatic Malformations. Journal of Global Oncology. Sept 2018;4(2). DOI: http://dx.doi.org/10.1200/jgo.18.92400

  10. Saha K, Leatherbarrow B. Orbital lymphangiomas: a review of management strategies. Current Opinion in Ophthalmology. 2012;23(5):433-8. DOI: http://dx.doi.org/10.1097/ICU.0b013e3283560a9910.

  11. Hanif AM, Saunders JA, Hawkins CM, Wojno TH, Kim HJ. Use of percutaneous bleomycin sclerotherapy for orbital lymphatic malformations. Orbit 2018 June 14 [Epub ahead of print]:1-7. DOI: http://dx.doi.org/10.1080/01676830.2018.148063611.

  12. Raichura ND, Alam MS, Noronha VO, Mukherjee B. A prospective study of the role of intralesional bleomycin in orbital lymphangioma. Journal of AAPOS. 2017;21(2):146-51. DOI: http://dx.doi.org/10.1016/j.jaapos.2017.03.00712.

  13. . Holemans C, Quaniers J, Boesmans E, Kerzmann A, Honoré P, Defraigne JO. Lymphangiome kystique rétropéritonéal traité par sildénafil. Rev Med Liege. 2020[acceso 18/03/2022];75:541-3. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/32779908/ 13.

  14. . U.S. National Library of Medicine. Phase II Clinical trial: A Study to Evaluate Sildenafil for the Treatment of Lymphatic Malformations [In course]. ClinicalTrials.gov. Identifier: NCT01290484. 2020.

  15. Haider M, Elsherbeny A, Pittalà V, Fallica AN, Alghamdi MA, Greish K. The Potential Role of Sildenafil in Cancer Management through EPR Augmentation. J Pers Med. 2021;11:585. DOI: http://dx.doi.org/10.3390/jpm1106058515.




2020     |     www.medigraphic.com